These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 18243643)

  • 1. Direct antiangiogenic actions of cadmium on human vascular endothelial cells.
    Woods JM; Leone M; Klosowska K; Lamar PC; Shaknovsky TJ; Prozialeck WC
    Toxicol In Vitro; 2008 Apr; 22(3):643-51. PubMed ID: 18243643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of mini-TyrRS-induced angiogenesis response in endothelial cells by VE-cadherin-dependent mini-TrpRS.
    Zeng R; Chen YC; Zeng Z; Liu XX; Liu R; Qiang O; Li X
    Heart Vessels; 2012 Mar; 27(2):193-201. PubMed ID: 21442253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Green tea catechins inhibit VEGF-induced angiogenesis in vitro through suppression of VE-cadherin phosphorylation and inactivation of Akt molecule.
    Tang FY; Nguyen N; Meydani M
    Int J Cancer; 2003 Oct; 106(6):871-8. PubMed ID: 12918064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective targeting of angiogenic tumor vasculature by vascular endothelial-cadherin antibody inhibits tumor growth without affecting vascular permeability.
    Liao F; Doody JF; Overholser J; Finnerty B; Bassi R; Wu Y; Dejana E; Kussie P; Bohlen P; Hicklin DJ
    Cancer Res; 2002 May; 62(9):2567-75. PubMed ID: 11980651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of the marine compound spongistatin 1 links the inhibition of PKCalpha translocation to nonmitotic effects of tubulin antagonism in angiogenesis.
    Rothmeier AS; Ischenko I; Joore J; Garczarczyk D; Fürst R; Bruns CJ; Vollmar AM; Zahler S
    FASEB J; 2009 Apr; 23(4):1127-37. PubMed ID: 19056838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of vascular endothelial growth factor-induced angiogenesis by resveratrol through interruption of Src-dependent vascular endothelial cadherin tyrosine phosphorylation.
    Lin MT; Yen ML; Lin CY; Kuo ML
    Mol Pharmacol; 2003 Nov; 64(5):1029-36. PubMed ID: 14573751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The soluble fragment of VE-cadherin inhibits angiogenesis by reducing endothelial cell proliferation and tube capillary formation.
    Li H; Shi X; Liu J; Hu C; Zhang X; Liu H; Jin J; Opolon P; Vannier JP; Perricaudet M; Janin A; Soria C; Lu H
    Cancer Gene Ther; 2010 Oct; 17(10):700-7. PubMed ID: 20559333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The VE-cadherin binding domain of fibrinogen induces endothelial barrier permeability and enhances transendothelial migration of malignant breast epithelial cells.
    Sahni A; Arévalo MT; Sahni SK; Simpson-Haidaris PJ
    Int J Cancer; 2009 Aug; 125(3):577-84. PubMed ID: 19358279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-angiogenic activity of a small molecule STAT3 inhibitor LLL12.
    Bid HK; Oswald D; Li C; London CA; Lin J; Houghton PJ
    PLoS One; 2012; 7(4):e35513. PubMed ID: 22530037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. VE-cadherin is a critical endothelial regulator of TGF-beta signalling.
    Rudini N; Felici A; Giampietro C; Lampugnani M; Corada M; Swirsding K; Garrè M; Liebner S; Letarte M; ten Dijke P; Dejana E
    EMBO J; 2008 Apr; 27(7):993-1004. PubMed ID: 18337748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extra cellular matrix derived metabolite regulates angiogenesis by FasL mediated apoptosis.
    Verma RK; Gunda V; Pawar SC; Sudhakar YA
    PLoS One; 2013; 8(12):e80555. PubMed ID: 24324608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular endothelial-cadherin stimulates syndecan-1-coupled insulin-like growth factor-1 receptor and cross-talk between αVβ3 integrin and vascular endothelial growth factor receptor 2 at the onset of endothelial cell dissemination during angiogenesis.
    Rapraeger AC; Ell BJ; Roy M; Li X; Morrison OR; Thomas GM; Beauvais DM
    FEBS J; 2013 May; 280(10):2194-206. PubMed ID: 23331867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of N-cadherin retards smooth muscle cell migration and intimal thickening via induction of apoptosis.
    Lyon CA; Koutsouki E; Aguilera CM; Blaschuk OW; George SJ
    J Vasc Surg; 2010 Nov; 52(5):1301-9. PubMed ID: 20630685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Confocal immunolocalization of VE-cadherin- and CXC chemokine-expressing endothelial cells in periapical granulomas.
    Takeichi O; Hama S; Iwata K; Ito K
    Int Endod J; 2008 May; 41(5):401-7. PubMed ID: 18298575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Luteolin inhibits smooth muscle cell migration and proliferation by attenuating the production of Nox4, p-Akt and VEGF in endothelial cells.
    Ding H; Li D; Zhang Y; Zhang T; Zhu H; Xu T; Luo Y; Wang C
    Curr Pharm Biotechnol; 2014; 14(12):1009-15. PubMed ID: 24433500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphorylation of VE-cadherin controls endothelial phenotypes via p120-catenin coupling and Rac1 activation.
    Hatanaka K; Simons M; Murakami M
    Am J Physiol Heart Circ Physiol; 2011 Jan; 300(1):H162-72. PubMed ID: 21037229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of retinal neovascularization with an antagonist to vascular endothelial cadherin.
    Navaratna D; Maestas J; McGuire PG; Das A
    Arch Ophthalmol; 2008 Aug; 126(8):1082-8. PubMed ID: 18695103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dissecting the Cellular Mechanism of Prostacyclin Analog Iloprost in Reversing Vascular Dysfunction in Scleroderma.
    Tsou PS; Palisoc PJ; Flavahan NA; Khanna D
    Arthritis Rheumatol; 2021 Mar; 73(3):520-529. PubMed ID: 33001586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. m-Calpain induction in vascular endothelial cells on human and mouse atheromas and its roles in VE-cadherin disorganization and atherosclerosis.
    Miyazaki T; Taketomi Y; Takimoto M; Lei XF; Arita S; Kim-Kaneyama JR; Arata S; Ohata H; Ota H; Murakami M; Miyazaki A
    Circulation; 2011 Dec; 124(23):2522-32. PubMed ID: 22064597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapamycin prevents endothelial cell migration by inhibiting the endothelial-to-mesenchymal transition and matrix metalloproteinase-2 and -9: an in vitro study.
    Gao H; Zhang J; Liu T; Shi W
    Mol Vis; 2011; 17():3406-14. PubMed ID: 22219636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.